Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus

NCT04510090 is registered in ClinicalTrials.gov with Escient Pharmaceuticals, Inc as lead sponsor.

NCT NCT04510090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04510090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus
Lead sponsor
Escient Pharmaceuticals, Inc
Phase
Phase 1
Overall status
Completed
Start date
September 7, 2020
Completion date
July 8, 2021
Enrollment
89 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cholestasis, kidney failure, pruritus